United States Oral Anticoagulants Market Report 2016

October 2016 | 122 pages | ID: U224BB211C8EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Oral Anticoagulants

Revenue, means the sales value of Oral Anticoagulants

This report studies sales (consumption) of Oral Anticoagulants in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Oral Anticoagulants in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Oral Anticoagulants Market Report 2016

1 ORAL ANTICOAGULANTS OVERVIEW

1.1 Product Overview and Scope of Oral Anticoagulants
1.2 Classification of Oral Anticoagulants
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Oral Anticoagulants
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Oral Anticoagulants (2011-2021)
  1.4.1 United States Oral Anticoagulants Sales and Growth Rate (2011-2021)
  1.4.2 United States Oral Anticoagulants Revenue and Growth Rate (2011-2021)

2 UNITED STATES ORAL ANTICOAGULANTS COMPETITION BY MANUFACTURERS

2.1 United States Oral Anticoagulants Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Oral Anticoagulants Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Oral Anticoagulants Average Price by Manufactures (2015 and 2016)
2.4 Oral Anticoagulants Market Competitive Situation and Trends
  2.4.1 Oral Anticoagulants Market Concentration Rate
  2.4.2 Oral Anticoagulants Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ORAL ANTICOAGULANTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Oral Anticoagulants Sales and Market Share by Type (2011-2016)
3.2 United States Oral Anticoagulants Revenue and Market Share by Type (2011-2016)
3.3 United States Oral Anticoagulants Price by Type (2011-2016)
3.4 United States Oral Anticoagulants Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ORAL ANTICOAGULANTS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Oral Anticoagulants Sales and Market Share by Application (2011-2016)
4.2 United States Oral Anticoagulants Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ORAL ANTICOAGULANTS MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Oral Anticoagulants Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Oral Anticoagulants Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Oral Anticoagulants Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Oral Anticoagulants Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Oral Anticoagulants Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Oral Anticoagulants Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Oral Anticoagulants Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Oral Anticoagulants Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Oral Anticoagulants Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Oral Anticoagulants Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 ORAL ANTICOAGULANTS MANUFACTURING COST ANALYSIS

6.1 Oral Anticoagulants Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Oral Anticoagulants

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Oral Anticoagulants Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Oral Anticoagulants Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ORAL ANTICOAGULANTS MARKET FORECAST (2016-2021)

10.1 United States Oral Anticoagulants Sales, Revenue Forecast (2016-2021)
10.2 United States Oral Anticoagulants Sales Forecast by Type (2016-2021)
10.3 United States Oral Anticoagulants Sales Forecast by Application (2016-2021)
10.4 Oral Anticoagulants Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oral Anticoagulants
Table Classification of Oral Anticoagulants
Figure United States Sales Market Share of Oral Anticoagulants by Type in 2015
Table Application of Oral Anticoagulants
Figure United States Sales Market Share of Oral Anticoagulants by Application in 2015
Figure United States Oral Anticoagulants Sales and Growth Rate (2011-2021)
Figure United States Oral Anticoagulants Revenue and Growth Rate (2011-2021)
Table United States Oral Anticoagulants Sales of Key Manufacturers (2015 and 2016)
Table United States Oral Anticoagulants Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oral Anticoagulants Sales Share by Manufacturers
Figure 2016 Oral Anticoagulants Sales Share by Manufacturers
Table United States Oral Anticoagulants Revenue by Manufacturers (2015 and 2016)
Table United States Oral Anticoagulants Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Oral Anticoagulants Revenue Share by Manufacturers
Table 2016 United States Oral Anticoagulants Revenue Share by Manufacturers
Table United States Market Oral Anticoagulants Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Oral Anticoagulants Average Price of Key Manufacturers in 2015
Figure Oral Anticoagulants Market Share of Top 3 Manufacturers
Figure Oral Anticoagulants Market Share of Top 5 Manufacturers
Table United States Oral Anticoagulants Sales by Type (2011-2016)
Table United States Oral Anticoagulants Sales Share by Type (2011-2016)
Figure United States Oral Anticoagulants Sales Market Share by Type in 2015
Table United States Oral Anticoagulants Revenue and Market Share by Type (2011-2016)
Table United States Oral Anticoagulants Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Oral Anticoagulants by Type (2011-2016)
Table United States Oral Anticoagulants Price by Type (2011-2016)
Figure United States Oral Anticoagulants Sales Growth Rate by Type (2011-2016)
Table United States Oral Anticoagulants Sales by Application (2011-2016)
Table United States Oral Anticoagulants Sales Market Share by Application (2011-2016)
Figure United States Oral Anticoagulants Sales Market Share by Application in 2015
Table United States Oral Anticoagulants Sales Growth Rate by Application (2011-2016)
Figure United States Oral Anticoagulants Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Oral Anticoagulants Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Oral Anticoagulants Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Oral Anticoagulants Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Oral Anticoagulants Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Oral Anticoagulants Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Oral Anticoagulants Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Oral Anticoagulants Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Oral Anticoagulants Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Oral Anticoagulants Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Oral Anticoagulants Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Oral Anticoagulants Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Anticoagulants
Figure Manufacturing Process Analysis of Oral Anticoagulants
Figure Oral Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Oral Anticoagulants Major Manufacturers in 2015
Table Major Buyers of Oral Anticoagulants
Table Distributors/Traders List
Figure United States Oral Anticoagulants Production and Growth Rate Forecast (2016-2021)
Figure United States Oral Anticoagulants Revenue and Growth Rate Forecast (2016-2021)
Table United States Oral Anticoagulants Production Forecast by Type (2016-2021)
Table United States Oral Anticoagulants Consumption Forecast by Application (2016-2021)